Neurological examination and measurement of biomarkers should be part of a multimodal approach to neuroprognostication in a comatose post–cardiac arrest patient.
This is a medical procedure which is used to determine if a patient has poor neurological prognosis.
This is done through measurement of biomarkers such as neuron-specific enolase (NSE) and other examinations.
Read more about Nervous system here https://brainly.com/question/869589
#SPJ12